Omeros OMER
NASDAQ OMER
$19.06 -0.19 (-1.01%)
As of: Sep 30, 2026 · 3:59 PM EDT

Omeros (OMER) Capital Leases (2017 - 2018)

Updated

Omeros (OMER) posted Capital Leases of $1.58 million for Q4 2018, up 94.8% from $810,000 a year earlier.

Analysis

Omeros (OMER) Capital Leases (2017 - 2018) Analysis & Trends

  • In prior years, Omeros' Capital Leases was $810,000 in FY2017.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 645.01 Bn 563.54 Bn 17.26 Bn
2 AbbVie 465.23 Bn 438.39 Bn 12.70 Bn
3 Merck 368.40 Bn 322.83 Bn 12.21 Bn
4 Novartis Ag 278.02 Bn 233.89 Bn 11.24 Bn
5 Astrazeneca 254.57 Bn 228.13 Bn 12.86 Bn
6 Amgen 229.02 Bn 184.42 Bn 7.24 Bn
7 Gilead Sciences 187.74 Bn 161.85 Bn 6.22 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn
9 Vertex Pharmaceuticals 133.45 Bn 105.45 Bn 2.84 Bn
10 Omeros 1.39 Bn 1.39 Bn 27.73 Mn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2018 1.58 Mn
Dec 31, 2017 810,000.00
API Access

Omeros Capital Leases API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=capital-leases&ticker=OMER&period=max&api_key=YOUR_API_KEY